Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients. [electronic resource]
Producer: 20130705Description: 1898-904 p. digitalISSN:- 1879-0852
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Analysis of Variance
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Carcinoma, Renal Cell -- drug therapy
- Cardiovascular Diseases -- chemically induced
- Disease Progression
- Drug Administration Schedule
- Everolimus
- Female
- Follow-Up Studies
- Humans
- Indoles -- administration & dosage
- Kaplan-Meier Estimate
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Pyrroles -- administration & dosage
- Sirolimus -- administration & dosage
- Sorafenib
- Sunitinib
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.